EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance

Xianfu Wei, Yan Zhang, Zhipeng Wang, Feiyue Lin, Qiang Yang, Long Chen

Cellular Oncology · 2026-12 · 49 (6)

DOI: 10.1007/s13402-026-01277-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 18.08.2026. Verfasst von Xianfu Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Osteosarcoma, RNA, Long Noncoding, Drug Resistance, Neoplasm, Bone Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, he Fujian Provincial Joint Research Program for Science and Technology Innovation, Fujian Provincial Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaRNA, Long NoncodingDrug Resistance, NeoplasmBone NeoplasmsHumansPrognosisGene Expression Regulation, NeoplasticAnimalsCell Line, TumorFemaleMale

Stichwörter der Autor:innen

CRLR-lncRNAChemoresistanceLactylationOsteosarcomaPrognostic signatureTumor immune microenvironment

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • School of Basic Medical Sciences, Shandong University, Jinan, China.
  • Department of Musculoskeletal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350000, China. feiyuelinsl@sina.com.
  • Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, Shandong, China. yangqiang_01@126.com.
  • Department of Musculoskeletal Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350000, China. chenlongcl56@163.com.

Förderung

  • National Natural Science Foundation of China
  • he Fujian Provincial Joint Research Program for Science and Technology Innovation
  • Fujian Provincial Natural Science Foundation Project

Zitieren

APA

Wei, X., Zhang, Y., Wang, Z., Lin, F., Yang, Q., & Chen, L. (2026). A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance. Cellular Oncology, 49(6). https://doi.org/10.1007/s13402-026-01277-4

Vancouver

Wei X, Zhang Y, Wang Z, Lin F, Yang Q, Chen L. A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance. Cellular Oncology. 2026;49(6). doi:10.1007/s13402-026-01277-4

BibTeX
@article{Wei2026,
  author = {Wei, Xianfu and Zhang, Yan and Wang, Zhipeng and Lin, Feiyue and Yang, Qiang and Chen, Long},
  title = {A chemoresistance- and lactylation-related lncRNA prognostic signature uncovers LINC01976/LDHA/lactylation regulatory axis in osteosarcoma chemoresistance},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {6},
  doi = {10.1007/s13402-026-01277-4}
}
Kostenlos starten →